
Wearables & metabolic — non-diabetic CGM category review
Levels, Lingo, Stelo, FreeStyle Libre Rio, Nutrisense, Signos — the non-diabetic CGM field, reviewed side by side
Six brands. Two sensor platforms. One question — which of these is actually worth strapping to your arm for two weeks, and which is asking you to subsidise a software wrapper around a $49 piece of Abbott or Dexcom hardware?
The US non-diabetic CGM market in 2026 collapses, structurally, into two sensor platforms (Abbott and Dexcom) and a fight over the app on top. Abbott's Lingo and FreeStyle Libre Rio run the same Libre 3-class sensor; Dexcom's Stelo runs a 15-day G7-class sensor; Levels, Nutrisense and Signos are software companies that resell one of those two sensors with a coaching layer and a subscription. The honest read: the hardware is excellent and largely interchangeable (Abbott MARD ~9%, Dexcom MARD ~8%). The differentiation is the timeline, the coaching, and the price tag — and on price tag, the software resellers are charging a 2–4x premium for an interpretation layer most users outgrow after week two. This category review ranks the field on cost-per-information, honesty of marketing, and whether the app actually changes behaviour or just dramatises it.
































